Lupus Research Alliance Response to Janssen’s Ustekinumab Lupus Trial Discontinuation
June 26, 2020
The Lupus Research Alliance is disappointed at news from Janssen Pharmaceutical Companies of Johnson & Johnson that...
Stories & News
Three Healthcare Organizations Issue Statement on FDA Action to End Emergency Authorization of Medications to Treat COVID-19
June 24, 2020
Joint Statement of the American Medical Association, American Pharmacists Association, and American Society of Health-System Pharmacists on...
New Study Presents Strategies That Helped African-Americans Take Part In Lupus Trials
June 22, 2020
African-Americans are more likely to develop lupus than Caucasians, but less likely to take part in clinical...
Why People with Lupus Must be More Careful Amid COVID-19
June 9, 2020
This may be hard to believe--since we are currently so immersed in the current pandemic—but COVID-19 and...
FDA Revoked Emergency Use Approval of Hydroxychloroquine for COVID-19
June 15, 2020
The U.S. Food and Drug Administration announced June 15 that it revoked approval called emergency use authorization...
LRA-Funded Findings Suggest Way to Help Reverse Lupus Nephritis
June 15, 2020
A recently published study explored how an unconventional treatment method undergoing clinical trials in cancer patients could...
New Guidelines from the ACR For Lupus Care During COVID-19 Pandemic
June 9, 2020
The American College of Rheumatology enlisted 14 experts on infectious diseases and immune system illnesses to develop...
A Message From LRA President & Ceo on COVID-19 and Lupus
These are challenging times for everyone-and each of us must stay focused. For the Lupus Research Alliance (LRA) this...
Watch Video of Webcast: Lupus and Cognitive Health
Watch a videotape of our recent webcast: Lupus and Cognitive Health
Presented by LRA’s Young Leaders Board
People with lupus know...
Promising News from Major Medical Meeting, EULAR
Updated June 5, 2020
One of the largest meetings for rheumatologists went virtual this year to enable scientists from around...
Lupus Research Alliance Issues Statement June 4, 2020
June 4, 2020
Racism, bigotry, intolerance and violence are hateful and have no place in American society.
The Lupus Research Alliance...
Positive Data from Trial of Investigational Treatment KZR-616 for Lupus and Lupus Nephritis
June 3, 2020
Kezar Life Sciences, Inc. today announced updated results from the Phase 1b (Ph1b) portion of MISSION, a...